Effect of Preoperative Diet on Perioperative Gut Microbiome

March 19, 2025 updated by: Cindy Kin, Stanford University

Can Low-fat/high-fiber or Fermented Diet Modulate the Gut Microbiome to Improve Surgical Outcomes?

The aim of the study is to evaluate the gut microbiome (i.e. bacteria, viruses, and fungi that reside in the gut) of people undergoing abdominal surgery, evaluate whether specific diets can change the gut microbiome, and, if so, whether those changes translate into better surgical outcomes.

Study Overview

Status

Active, not recruiting

Detailed Description

Standard of care: patients undergoing major abdominal colorectal surgery are sometimes advised to eat healthfully prior to surgery, but without more specific recommendations regarding their diet.

Research Activities:

  1. Screening: eligible patients will be identified through screening the clinic schedules.
  2. Enrollment: in person or remotely, after the patient is determined to require major abdominal surgery, they will be invited to participate in the study. If they consent to participate, they will be randomized to receive either low-fat/high-fiber diet, high-fermented diet, or continue with their normal diet for 10-14 days prior to the surgery.
  3. Intervention: at baseline, data will be collected regarding clinical information of the patients (age, body mass index, comorbidities, medications or supplements, physical activity levels, antibiotic or probiotic use in the past six months), and baseline dietary pattern, which will be evaluated through application of a validated Food Frequency Questionnaire (DHQ III). Patients in the intervention arms (low- fat/high-fiber diet or high-fermented diet) will receive meal samples during the 10-14 days preceding surgery. Patients in the control arm will receive a $25 grocery voucher. Adherence to the diet will be assessed through regular check ins with the patients.

    Stool samples will be collected in five timepoints: at the beginning of the study, after the dietary intervention, during surgery, in the first week after the surgery, and between 21-30 days after surgery. The stool samples will be sent for analysis of the microbiome.

    A fragment of the resected bowel will also be sent for analysis of the mucosal-associated microbiome.

  4. Closeout: After surgery, all patients will receive the same standard dietary protocol and care, and will be followed for 30 days without any further intervention.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Stanford, California, United States, 94305
        • Stanford Health Care

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • undergoing major abdominal colorectal surgery with intestinal resection in 2 or more weeks

Exclusion Criteria:

  • patients who do not speak English or Spanish
  • houseless patients
  • decisionally impaired patients
  • presence of ileostomy prior to the surgical procedure
  • surgery without intestinal resection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Arm
Standard care - patients will not receive specific dietary advice.
Experimental: High Fiber/low fat
Patients will receive sample meals and education/support, will be asked to follow this diet for 10 days.
high fiber/low fat preoperative diet
Experimental: Fermented
Patients will receive sample meals and education/support, will be asked to follow this diet for 10 days.
fermented preoperative diet

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in gut microbiome alpha and beta diversity according to pre-operative diet intervention
Time Frame: Two weeks prior to surgery
Metagenomic sequencing will be performed on stool samples before and after dietary change.
Two weeks prior to surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in gut microbiome alpha and beta diversity after surgery according to pre-operative diet
Time Frame: Surgery date until 1 month after surgery
Metagenomic sequencing will be performed on stool samples collected in the first week after surgery and 30 days after surgery
Surgery date until 1 month after surgery
Frequency and severity of surgical complications according to pre-operative diet
Time Frame: 30 days after surgery
Comprehensive Complication Index (CCI) score will be used to measure number and severity of surgical complications occurring within 30 days after surgery. Comprehensive Complication Index score includes minimum value of 0 and maximum value of 100; higher score means higher severity of complication(s).
30 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2022

Primary Completion (Estimated)

June 1, 2025

Study Completion (Estimated)

September 20, 2025

Study Registration Dates

First Submitted

August 17, 2021

First Submitted That Met QC Criteria

August 25, 2021

First Posted (Actual)

August 30, 2021

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 19, 2025

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 62330

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgical Site Infection

Clinical Trials on high-fiber/low fat

Subscribe